|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2005-7-11
|
|
pubmed:abstractText |
Candida endophthalmitis represents the most serious ocular complication of candidemia. The pharmacokinetics and pharmacodynamics of fluconazole, amphotericin B, and flucytosine are fairly well established in endophthalmitis therapy. There remains a paucity of clinical data regarding the utility of new antimycotic agents in the treatment of fungal chorioretinitis and endophthalmitis. We report a case of clinical failure of caspofungin in the management of Candida albicans endophthalmitis associated with poor vitreous penetration.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
1537-6591
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
1
|
|
pubmed:volume |
41
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
e27-8
|
|
pubmed:dateRevised |
2008-9-25
|
|
pubmed:meshHeading |
pubmed-meshheading:16007519-Adult,
pubmed-meshheading:16007519-Amphotericin B,
pubmed-meshheading:16007519-Antifungal Agents,
pubmed-meshheading:16007519-Candidiasis,
pubmed-meshheading:16007519-Drug Combinations,
pubmed-meshheading:16007519-Echinocandins,
pubmed-meshheading:16007519-Endophthalmitis,
pubmed-meshheading:16007519-Humans,
pubmed-meshheading:16007519-Male,
pubmed-meshheading:16007519-Peptides, Cyclic,
pubmed-meshheading:16007519-Phosphatidylcholines,
pubmed-meshheading:16007519-Phosphatidylglycerols,
pubmed-meshheading:16007519-Treatment Failure
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Subtherapeutic ocular penetration of caspofungin and associated treatment failure in Candida albicans endophthalmitis.
|
|
pubmed:affiliation |
Department of Medicine, University of Wisconsin-Madison, Madison, WI, USA.
|
|
pubmed:publicationType |
Journal Article,
Case Reports
|
